Ensign Peak Advisors’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.78M | Hold |
215,454
| – | – | 0.01% | 653 |
|
|
2025
Q1 | $4.01M | Hold |
215,454
| – | – | 0.01% | 685 |
|
|
2024
Q4 | $2.85M | Buy |
215,454
+139,699
| +184% | +$1.85M | 0.01% | 804 |
|
|
2024
Q3 | $2.54M | Hold |
75,755
| – | – | ﹤0.01% | 848 |
|
|
2024
Q2 | $1.9M | Buy |
75,755
+32,313
| +74% | +$810K | ﹤0.01% | 934 |
|
|
2024
Q1 | $978K | Hold |
43,442
| – | – | ﹤0.01% | 1335 |
|
|
2023
Q4 | $931K | Hold |
43,442
| – | – | ﹤0.01% | 1429 |
|
|
2023
Q3 | $780K | Hold |
43,442
| – | – | ﹤0.01% | 1385 |
|
|
2023
Q2 | $884K | Hold |
43,442
| – | – | ﹤0.01% | 1363 |
|
|
2023
Q1 | $945K | Hold |
43,442
| – | – | ﹤0.01% | 1286 |
|
|
2022
Q4 | $1.35M | Sell |
43,442
-4,800
| -10% | -$149K | ﹤0.01% | 967 |
|
|
2022
Q3 | $1.23M | Buy |
48,242
+2,900
| +6% | +$73.9K | ﹤0.01% | 966 |
|
|
2022
Q2 | $921K | Hold |
45,342
| – | – | ﹤0.01% | 1149 |
|
|
2022
Q1 | $1.12M | Buy |
45,342
+510
| +1% | +$12.6K | ﹤0.01% | 1131 |
|
|
2021
Q4 | $1.56M | Buy |
44,832
+1,390
| +3% | +$48.3K | ﹤0.01% | 1063 |
|
|
2021
Q3 | $1.18M | Buy |
+43,442
| New | +$1.18M | ﹤0.01% | 1373 |
|
|
2020
Q4 | – | Sell |
-23,005
| Closed | -$339K | – | 1856 |
|
|
2020
Q3 | $339K | Buy |
+23,005
| New | +$339K | ﹤0.01% | 1600 |
|